Fusion Antibodies logo

FAB - Fusion Antibodies Share Price

70p 0.0  0.0%

Last Trade - 12/11/19

Sector
Healthcare
Size
Micro Cap
Market Cap £15.5m
Enterprise Value £13.6m
Revenue £2.18m
Position in Universe 1435th / 1849
Bullish
Bearish
Unlock FAB Revenue
Momentum
Relative Strength (%)
1m
3m
6m
1yr
Volume Change (%)
10d / 3m
Price vs... (%)
52w High
50d MA
200d MA
Margin of Safety
Qualifying GuruScreens
Health Trend(F-Score)
0 1 2 3 4 5 6 7 8 9
Bankruptcy Score(Z-Score)
Distress
Cautious
Safe
Earnings Manipulation Risk(M-Score)
Other Ratios
Recent History
Latest interim period vs. prior period Industry Market
3yr Compound Annual Growth Rate Industry Market
Graphical History

Revenue

FAB Revenue Unlock FAB Revenue

Net Income

FAB Net Income Unlock FAB Revenue

Normalised EPS

FAB Normalised EPS Unlock FAB Revenue

PE Ratio Range

FAB PE Ratio Range Unlock FAB Revenue

Dividend Yield Range

FAB Dividend Yield Range Unlock FAB Revenue
Analyst Forecasts
Price Target:
( below Price)
31st Dec 2019
31st Dec 2020
Est. Long Term Growth Rate: Net Profit
()
EPS
()
DPS
()
Net Profit
()
EPS
()
DPS
()
Consensus Estimate
1m Change
3m Change
Analyst Consensus
Strong Sell Sell Hold Buy Strong Buy
EPS 2019 /  2020
FAB EPS Forecasts Unlock FAB Revenue
Profile Summary

Fusion Antibodies PLC, formerly Fusion Antibodies, Ltd., is a United Kingdom-based cancer therapeutics developer. The Company develops and commercializes antibody-based therapeutics for cancer. The Company develops a range of antibody engineering services based around monoclonal antibodies. It focuses in the expression and purification of recombinant proteins and chimeric antibodies for the research, diagnostic and therapeutic markets. Its technology generates target specific antibodies from protein antigens. The Company's therapeutic and diagnostic research and development are offered as a service to pharmaceutical, biopharmaceutical and academic researchers.

Directors
Last Annual March 31st, 2019
Last Interim March 31st, 2019
Incorporated November 29, 2000
Public Since December 18, 2017
No. of Shareholders: n/a
No. of Employees: 30
Sector Healthcare
Industry Biotechnology & Medical Research
Index FTSE Aim All Share ,
Exchange London Stock Exchange (Full)
Shares in Issue 22,091,192
Free Float (0.0%)
Eligible for
ISAs
SIPPs
FAB Share Price Performance
Share Price
Bid - Ask
Low - High
Spread
Day's Change
Avg Volume
Open - Close
Range (12m)
Beta
Latest News for FAB
Upcoming Events for FAB
Similar to FAB
© Stockopedia 2019, Thomson Reuters, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.